National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 8/3/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

J. Pablo Arnoletti, MD

None

None

None

None

None

Stephen Behrman, MD

None

None

None

None

None

Edgar Ben-Josef, MD

None

None

None

None

None

Al B. Benson III, MD, FACP, FASCO

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

Ephraim S. Casper, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Steven J. Cohen, MD

None

None

None

None

None

Brian Czito, MD

None

None

None

None

None

Michelle Duff, DPT

None

AstraZeneca Pharmaceuticals LP

None

None

None

Joshua D.I. Ellenhorn, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

William G. Hawkins, MD

None

None

None

None

None

Joseph Herman, MD

None

None

None

None

None

John P. Hoffman, MD

None

None

None

None

None

Srinadh Komanduri, MD

None

None

None

None

None

Albert Koong, MD, PhD

None

None

None

None

None

Boris W. Kuvshinoff, MD, MBA

None

None

None

None

None

Mokenge P. Malafa, MD, FACS

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nipun B. Merchant, MD

None

None

None

None

None

Sean J. Mulvihill, MD

National Cancer Institute

None

None

None

None

Peter Muscarella II, MD

None

None

None

None

None

Eric K. Nakakura, MD

None

None

None

None

None

Jorge Obando, MD

None

None

None

None

None

Martha B. Pitman, MD

None

None

None

None

None

Aaron R. Sasson, MD

None

None

None

None

None

Dorothy Shead, MS

None

None

None

None

None

Margaret A. Tempero, MD

None

Abraxis Bioscience, Inc.;
Celgene Corporation;
Myriad Genetic Laboratories, Inc.;
Elsevier Publishing/OncologySTAT;
GenMab;
Medigene;
Pancreatic Cancer Action Network;
Rexahn Pharmaceuticals;
V Foundation;
Wayne D. Kuni and Joan E. Kuni Foundation;
sanofi-aventis U.S.

None

None

None

Sarah P. Thayer, MD, PhD

None

Lustgarten Foundation

None

None

None

Robert S. Warren, MD

None

None

None

None

None

Samuel Whiting, MD, PhD

None

Genentech, Inc.

None

None

None

Robert A. Wolff, MD

None

None

None

None

None

Brian M. Wolpin, MD, MPH

None

None

None

None

None